BACKGROUND: Abnormalities in the corpus callosum have long been implicated in schizophrenia. Previous diffusion tensor imaging (DTI) studies in patients with different durations of schizophrenia yielded inconsistent results. By comparing patients with different durations of schizophrenia, we investigated if white matter abnormalities of the corpus callosum emerge at an early stage in the illness or result from pathological progression. METHODS: We recruited patients with first-episode schizophrenia, patients with chronic schizophrenia and age-, sex- and handedness-matched healthy controls. We used 2 DTI techniques (voxel-based and fibre-tracking DTI) to investigate differences in corpus callosum integrity among the 3 groups. RESULTS: With both DTI techniques, significantly decreased fractional anisotropy values were identified in the genu of corpus callosum in patients with chronic schizophrenia, but not first-episode schizophrenia, compared with healthy controls. LIMITATIONS: This study was cross-sectional, and the sample size was relatively small. CONCLUSION: Abnormalities in the genu of the corpus callosum might be a progressive process in schizophrenia, perhaps related to disease severity and prognosis.
BACKGROUND: Abnormalities in the corpus callosum have long been implicated in schizophrenia. Previous diffusion tensor imaging (DTI) studies in patients with different durations of schizophrenia yielded inconsistent results. By comparing patients with different durations of schizophrenia, we investigated if white matter abnormalities of the corpus callosum emerge at an early stage in the illness or result from pathological progression. METHODS: We recruited patients with first-episode schizophrenia, patients with chronic schizophrenia and age-, sex- and handedness-matched healthy controls. We used 2 DTI techniques (voxel-based and fibre-tracking DTI) to investigate differences in corpus callosum integrity among the 3 groups. RESULTS: With both DTI techniques, significantly decreased fractional anisotropy values were identified in the genu of corpus callosum in patients with chronic schizophrenia, but not first-episode schizophrenia, compared with healthy controls. LIMITATIONS: This study was cross-sectional, and the sample size was relatively small. CONCLUSION: Abnormalities in the genu of the corpus callosum might be a progressive process in schizophrenia, perhaps related to disease severity and prognosis.
Authors: Warrick J Brewer; Stephen J Wood; Lisa J Phillips; Shona M Francey; Christos Pantelis; Alison R Yung; Barbara Cornblatt; Patrick D McGorry Journal: Schizophr Bull Date: 2006-06-16 Impact factor: 9.306
Authors: M Kubicki; M Styner; S Bouix; G Gerig; D Markant; K Smith; R Kikinis; R W McCarley; M E Shenton Journal: Schizophr Res Date: 2008-09-30 Impact factor: 4.939
Authors: Bart D Peters; Lieuwe de Haan; Nienke Dekker; Jorik Blaas; Hiske E Becker; Peter M Dingemans; Erik M Akkerman; Charles B Majoie; Therèse van Amelsvoort; Gerard J den Heeten; Don H Linszen Journal: Neuropsychobiology Date: 2008-09-10 Impact factor: 2.328
Authors: Serge A Mitelman; Yekaterina K Nikiforova; Emily L Canfield; Erin A Hazlett; Adam M Brickman; Lina Shihabuddin; Monte S Buchsbaum Journal: Schizophr Res Date: 2009-08-26 Impact factor: 4.939
Authors: Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian Journal: Arch Gen Psychiatry Date: 2003-05
Authors: Joseph I Friedman; Cheuk Tang; David Carpenter; Monte Buchsbaum; James Schmeidler; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou; Johnny Ng; Patrick R Hof; Philip D Harvey; Nicholas D Tsopelas; Daniel Stewart; Kenneth L Davis Journal: Am J Psychiatry Date: 2008-06-16 Impact factor: 18.112
Authors: Emily C Balevich; M Mehmet Haznedar; Eugene Wang; Randall E Newmark; Rachel Bloom; Jason S Schneiderman; Jonathan Aronowitz; Cheuk Y Tang; King-Wai Chu; William Byne; Monte S Buchsbaum; Erin A Hazlett Journal: Psychiatry Res Date: 2015-01-08 Impact factor: 3.222
Authors: Patricia Alvarado-Alanis; Pablo León-Ortiz; Francisco Reyes-Madrigal; Rafael Favila; Oscar Rodríguez-Mayoral; Humberto Nicolini; Mariana Azcárraga; Ariel Graff-Guerrero; Laura M Rowland; Camilo de la Fuente-Sandoval Journal: Schizophr Res Date: 2015-01-22 Impact factor: 4.939
Authors: Sean N Hatton; Jim Lagopoulos; Daniel F Hermens; Ian B Hickie; Elizabeth Scott; Maxwell R Bennett Journal: J Psychiatry Neurosci Date: 2014-11 Impact factor: 6.186
Authors: Laurena Holleran; Mohamed Ahmed; Heike Anderson-Schmidt; John McFarland; Louise Emsell; Alexander Leemans; Cathy Scanlon; Peter Dockery; Peter McCarthy; Gareth J Barker; Colm McDonald; Dara M Cannon Journal: Neuropsychopharmacology Date: 2013-10-22 Impact factor: 7.853